CDKN3 and cutaneous squamous cell carcinoma: These findings are consistent with the previous report that MAGEA12 down-regulated the cyclin-dependent kinase inhibitors (p21) and involved in the pathogenesis of cutaneous squamous cell carcinoma [33].